# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA2319268 | F | Antitumor activity in mouse H22 liver cancer cells inoculated mouse assessed as tumor inhibition rate at one fifth of LD50 concentration once a day for consecutive 7 days by ip | Mus musculus | 12 | cell-based format | Scientific Literature | ||
2. | ALA2319269 | F | Antitumor activity in mouse B16 melanoma cell lines cells inoculated mouse assessed as tumor inhibition rate at one fifth of LD50 concentration once a day for consecutive 7 days by ip | Mus musculus | 12 | cell-based format | Scientific Literature | ||
3. | ALA2319270 | F | Antitumor activity in mouse Sarcoma 180 cells inoculated mouse assessed as tumor inhibition rate at one fifth of LD50 concentration once a day for consecutive 7 days by ip | Mus musculus | 12 | cell-based format | Scientific Literature | ||
4. | ALA2319271 | F | Antitumor activity in mouse Lewis lung cancer cells inoculated mouse assessed as tumor inhibition rate at one fifth of LD50 concentration once a day for consecutive 7 days by ip | Mus musculus | 12 | cell-based format | Scientific Literature | ||
5. | ALA2319272 | F | Antitumor activity in mouse CT26 colon cancer cells inoculated mouse assessed as tumor inhibition rate at one fifth of LD50 concentration once a day for consecutive 7 days by ip | Mus musculus | 12 | cell-based format | Scientific Literature | ||
6. | ALA2319274 | T | Toxicity in C57BL/6 mouse assessed as maximum weight loss at 50 mg/kg, ip | Mus musculus | 2 | organism-based format | Scientific Literature | ||
7. | ALA2319278 | T | Toxicity in C57BL/6 mouse assessed as liver damage at 1 to 500 mg/kg, ip for 14 days | Mus musculus | 43 | organism-based format | Scientific Literature | ||
8. | ALA2319279 | T | Toxicity in C57BL/6 mouse assessed as kidney damage at 1 to 500 mg/kg, ip for 14 days | Mus musculus | 43 | organism-based format | Scientific Literature | ||
9. | ALA2319280 | T | Toxicity in C57BL/6 mouse assessed as heart damage at 1 to 500 mg/kg, ip for 14 days | Mus musculus | 43 | organism-based format | Scientific Literature | ||
10. | ALA2319531 | T | Neurotoxicity in C57BL/6 mouse at 1 to 500 mg/kg, ip for 14 days | Mus musculus | 11 | organism-based format | Scientific Literature | ||
11. | ALA2319532 | T | Acute toxicity in ip treated C57BL/6 mouse for 14 days | Mus musculus | 11 | organism-based format | Scientific Literature | ||
12. | ALA2319533 | F | Cytotoxicity against human ovary adenocarcinoma SKOV3 cells assessed as reduction in optical density by MTT assay | Homo sapiens | 45 | cell-based format | Scientific Literature | ||
13. | ALA2319534 | F | Cytotoxicity against human epidermoid carcinoma of the nasopharynx KB cells assessed as reduction in optical density by MTT assay | Homo sapiens | 45 | cell-based format | Scientific Literature | ||
14. | ALA2319535 | F | Cytotoxicity against human renal carcinoma 769-P cells assessed as reduction in optical density by MTT assay | Homo sapiens | 45 | cell-based format | Scientific Literature | ||
15. | ALA2319536 | F | Cytotoxicity against human malignant melanoma A375 cells assessed as reduction in optical density by MTT assay | Homo sapiens | 45 | cell-based format | Scientific Literature | ||
16. | ALA2319537 | F | Cytotoxicity against human gastric carcinoma BGC823 cells assessed as reduction in optical density by MTT assay | Homo sapiens | 45 | cell-based format | Scientific Literature |